Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
NPJ Precision Oncology
|
March 20, 2025
Revealing neuroendocrine transformation in gynecological cancers through genomic analysis
Ann Oluloro, David L Wells, Charles K Childers, et al.
Cancer Treatment and Research Communications
|
November 1, 2025
Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer
Kevin M Levine, Natalie F Uy, Ted A Gooley, et al.
BMC Cancer
|
October 5, 2012
A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer
Julie E Bauman, Keith D Eaton, Sarah G Wallace, et al.
Plos One
|
June 14, 2013
Plasma processing conditions substantially influence circulating microRNA biomarker levels
Heather H Cheng, Hye Son Yi, Yeonju Kim, et al.
Investigational New Drugs
|
January 16, 2018
A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors
Gentry T King, Keith D Eaton, Brandon R Beagle, et al.
American Journal of Clinical Pathology
|
July 18, 2015
Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients
Min Fang, Pamela S Becker, Michael Linenberger, et al.
Journal of Oncology Practice
|
February 18, 2018
Characterizing Potentially Preventable Cancer- and Chronic Disease-Related Emergency Department Use in the Year After Treatment Initiation: A Regional Study
Laura Panattoni, Catherine Fedorenko, Mikael Anne Greenwood-Hickman, et al.
The Laryngoscope
|
December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma
Bruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 5, 2016
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
Sai-Hong Ignatius Ou, Ramaswamy Govindan, Keith D Eaton, et al.
Oral Oncology
|
November 21, 2021
Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution
Perrin E Romine, Jenna Voutsinas, Vicky Wu, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
NPJ Precision Oncology
|
March 20, 2025
Revealing neuroendocrine transformation in gynecological cancers through genomic analysis
Ann Oluloro, David L Wells, Charles K Childers, et al.
Cancer Treatment and Research Communications
|
November 1, 2025
Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer
Kevin M Levine, Natalie F Uy, Ted A Gooley, et al.
BMC Cancer
|
October 5, 2012
A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer
Julie E Bauman, Keith D Eaton, Sarah G Wallace, et al.
Plos One
|
June 14, 2013
Plasma processing conditions substantially influence circulating microRNA biomarker levels
Heather H Cheng, Hye Son Yi, Yeonju Kim, et al.
Investigational New Drugs
|
January 16, 2018
A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors
Gentry T King, Keith D Eaton, Brandon R Beagle, et al.
American Journal of Clinical Pathology
|
July 18, 2015
Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients
Min Fang, Pamela S Becker, Michael Linenberger, et al.
Journal of Oncology Practice
|
February 18, 2018
Characterizing Potentially Preventable Cancer- and Chronic Disease-Related Emergency Department Use in the Year After Treatment Initiation: A Regional Study
Laura Panattoni, Catherine Fedorenko, Mikael Anne Greenwood-Hickman, et al.
The Laryngoscope
|
December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma
Bruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 5, 2016
Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
Sai-Hong Ignatius Ou, Ramaswamy Govindan, Keith D Eaton, et al.
Oral Oncology
|
November 21, 2021
Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution
Perrin E Romine, Jenna Voutsinas, Vicky Wu, et al.
Page
of 6